E. S. Platonova
Research Subjects
E. S. Platonova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Sermavbrina
Pavlov Ryazan State Medical University
1 shared publication - Gleb Vladimirovich Nozhov
Pavlov Ryazan State Medical University
1 shared publication - Kristina Gennadievna Pereverzeva
Department of Hospital Therapy, Ryazan State Medical University, 390026 Ryazan, Russia
1 shared publication - S. S. Zagorodniy
Regional Clinical Cardiology Dispensary
1 shared publication А. В. Сермавбрина
ФГБОУ ВО «Рязанский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России
1 shared publicationГ. В. Ножов
ФГБОУ ВО «Рязанский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (4) , 335-342
Factors associated with adverse outcomes within two years after myocardial infarction in young patients
Aim . To identify independent clinical, laboratory, and instrumental factors associated with the occurrence of a composite endpoint (CEP) within two years in young patients (≤44 years) who have suffered an acute myocardial infarction (AMI). Material and methods . This single-center retrospective study included 331 patients (median age 41 years, 91.5% male) with AMI treated between 2015–2023. Inclusion criteria were: age ≤44 years, confirmed AMI diagnosis, and availability of coronary angiography (CAG). The CEP included recurrent AMI, emergency hospitalisations for cardiovascular reasons, and death during the two-year follow-up period. Patients were divided into a group that reached the CEP (Event, n=30) and a group that did not (Non-Event, n=301). Results . Over the two-year period, the CEP was recorded in 9% of patients. The groups differed significantly in the prevalence of diabetes mellitus/impaired glucose tolerance (46.7% vs. 16.3%; pConclusion . In young postAMI patients, the risk of adverse twoyear outcomes is determined primarily by fasting glucose levels and left atrial size, rather than by the anatomical extent of atherosclerosis. These findings support a personalised approach to secondary prevention with a focus on glycemic control and assessment of structuralfunctional cardiac parameters.
- 28 October 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (4) , 335-342
Open AccessFactors associated with adverse outcomes within two years after myocardial infarction in young patients
Aim . To identify independent clinical, laboratory, and instrumental factors associated with the occurrence of a composite endpoint (CEP) within two years in young patients (≤44 years) who have suffered an acute myocardial infarction (AMI). Material and methods . This single-center retrospective study included 331 patients (median age 41 years, 91.5% male) with AMI treated between 2015–2023. Inclusion criteria were: age ≤44 years, confirmed AMI diagnosis, and availability of coronary angiography (CAG). The CEP included recurrent AMI, emergency hospitalisations for cardiovascular reasons, and death during the two-year follow-up period. Patients were divided into a group that reached the CEP (Event, n=30) and a group that did not (Non-Event, n=301). Results . Over the two-year period, the CEP was recorded in 9% of patients. The groups differed significantly in the prevalence of diabetes mellitus/impaired glucose tolerance (46.7% vs. 16.3%; pConclusion . In young postAMI patients, the risk of adverse twoyear outcomes is determined primarily by fasting glucose levels and left atrial size, rather than by the anatomical extent of atherosclerosis. These findings support a personalised approach to secondary prevention with a focus on glycemic control and assessment of structuralfunctional cardiac parameters.